The changes in ERK1/2 activities appear to be a key mechanism for the regulation of depression by paeoniflorin, as ERK1/2 inhibition can abolish the antidepressant effect of paeoniflorin (Zhong et al., 2019). The gene discussed is MAPK3; the disease is depressive symptom measurement.